Abstract
Background: Sepsis is a disease with a high mortality rate without prompt treatment. However, this entity is difficult to diagnose in the elderly population in the emergency room; for this reason, it is necessary to have diagnostic tools for early detection. Objective: The aim of the study was to determine the highest diagnostic yield of procalcitonin (PCT), Quick Sequential Organ Failure Assessment (qSOFA), and Sequential Organ Failure Assessment (SOFA) for sepsis (based on the sepsis-3 consensus), on admission at the emergency department, in those older than 65 years. Methods: This is a diagnostic test study of a historical cohort of 65-year-old patients with suspected sepsis. Results: In the sample of 179 patients, 53.6% had confirmed sepsis. Significant differences were found (p < 0.0001), with a greater diagnostic and predictive capacity of PCT for the diagnosis of sepsis (receiver operating characteristics curve area [area under the curve (AUC) = 0.883, 95% CI: 0.835–0.931] than qSOFA (AUC = 0.559, 95% CI: 0.485–0.663) and SOFA (AUC = 0.662, 95% CI: 0.584–0.739); these results were similar in the cohort of patients ≥75 years. In positive PCT(≥0.5 ng/mL), the sensitivity was 71.8% (95% CI: 62.36–81.39), specificity of 89.1% (95% CI: 81.87–96.45%), V+ 88.4% (95% CI: 80.73–96.19%), V− of 73.2% (95% CI: 64.14–82.39%), positive likelihood ratio of 6.63 (95% CI: 3.53–12.44), and negative likelihood ratio of 0.32 (95% CI: 0.23–0.44); these results were similar in the cohort of patients ≥75 years. Lactate ≥2 mmol/L (RR = 1.659 [95% CI: 1.002–2.747]) and PCT ≥0.5 ng/mL (RR = 1.942 [95% CI: 1.157–3.261]) showed a significant association with in-hospital mortality. Conclusion: In the elderly population with suspicion of infection on admission to the emergency department, qSOFA presents a low diagnostic performance of confirmed sepsis and in-hospital mortality, for which other tools with higher diagnostic and prognostic performance should be added, such as PCT and lactate.
References
1.
Gaieski
DF
, Edwards
JM
, Kallan
MJ
, Carr
BG
. Benchmarking the incidence and mortality of severe sepsis in the United States
. Crit Care Med
. 2013
;41
(5
):1167
–74
. .2.
GBD 2013 Mortality and Causes of Death Collaborators
. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013
. Lancet
. 2015
;385
(9963
):117
–71
. 3.
Girard
TD
, Opal
SM
, Ely
EW
. Insights into severe sepsis in older patients: from epidemiology to evidence-based management
. Clin Infect Dis
. 2005
;40
(5
):719
–27
. .4.
Singer
M
, Deutschman
CS
, Seymour
CW
, Shankar-Hari
M
, Annane
D
, Bauer
M
, The third international consensus definitions for sepsis and septic shock (sepsis-3)
. JAMA
. 2016
;315
(8
):801
–10
. .5.
Vincent
JL
, Moreno
R
, Takala
J
, Willatts
S
, De Mendonça
A
, Bruining
H
, The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on sepsis-related problems of the European Society of Intensive Care Medicine
. Intensive Care Med
. 1996
;22
(7
):707
–10
. .6.
Lambden
S
, Laterre
PF
, Levy
MM
, Francois
B
. The SOFA score-development, utility and challenges of accurate assessment in clinical trials
. Crit Care
. 2019
;23
(1
):374
. .7.
Hogan
TM
, Losman
ED
, Carpenter
CR
, Sauvigne
K
, Irmiter
C
, Emanuel
L
, Development of geriatric competencies for emergency medicine residents using an expert consensus process
. Acad Emerg Med
. 2010
;17
(3
):316
–24
. .8.
Shenvi
CL
, Platts-Mills
TF
. Managing the elderly emergency department patient
. Ann Emerg Med
. 2019
;73
(3
):302
–7
. .9.
Maruna
P
, Nedelníková
K
, Gürlich
R
. Physiology and genetics of procalcitonin
. Physiol Res
. 2000
;49
(Suppl 1
):S57
–61
.10.
Meisner
M
. Update on procalcitonin measurements
. Ann Lab Med
. 2014
;34
(4
):263
–73
. .11.
Hunold
KM
, Pereira
GF
, Jones
CW
, Isaacs
CG
, Braz
VA
, Gadi
SR
, Priorities of care among older adults in the emergency department: a cross-sectional study
. Acad Emerg Med
. 2016
;23
(3
):362
–5
. .12.
Angus
DC
, Linde-Zwirble
WT
, Lidicker
J
, Clermont
G
, Carcillo
J
, Pinsky
MR
. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care
. Crit Care Med
. 2001
;29
(7
):1303
–10
. .13.
Goto
T
, Yoshida
K
, Tsugawa
Y
, Camargo
CA
Jr, Hasegawa
K
. Infectious disease-related emergency department visits of elderly adults in the United States, 2011–2012
. J Am Geriatr Soc
. 2016
;64
(1
):31
–6
. .14.
Luethi
N
, Bailey
M
, Higgins
A
, Howe
B
, Peake
S
, Delaney
A
, Gender differences in mortality and quality of life after septic shock: a post-hoc analysis of the ARISE study
. J Crit Care
. 2020
;55
:177
–83
. .15.
Nguyen
HB
, Rivers
EP
, Knoblich
BP
, Jacobsen
G
, Muzzin
A
, Ressler
JA
, Early lactate clearance is associated with improved outcome in severe sepsis and septic shock
. Crit Care Med
. 2004
;32
(8
):1637
–42
. .16.
Nguyen
HB
, Jaehne
AK
, Jayaprakash
N
, Semler
MW
, Hegab
S
, Yataco
AC
, Early goal-directed therapy in severe sepsis and septic shock: insights and comparisons to ProCESS, ProMISe, and ARISE
. Crit Care
. 2016
;20
(1
):160
. .17.
Arefian
H
, Heublein
S
, Scherag
A
, Brunkhorst
FM
, Younis
MZ
, Moerer
O
, Hospital-related cost of sepsis: a systematic review
. J Infect
. 2017
;74
(2
):107
–17
. .18.
Martin
GS
, Mannino
DM
, Moss
M
. The effect of age on the development and outcome of adult sepsis
. Crit Care Med
. 2006
;34
(1
):15
–21
. .19.
Lane
DJ
, Wunsch
H
, Saskin
R
, Cheskes
S
, Lin
S
, Morrison
LJ
, Screening strategies to identify sepsis in the prehospital setting: a validation study
. CMAJ
. 2020
;192
(10
):E230
–e9
. .20.
Baumann
BM
, Greenwood
JC
, Lewis
K
, Nuckton
TJ
, Darger
B
, Shofer
FS
, Combining qSOFA criteria with initial lactate levels: improved screening of septic patients for critical illness
. Am J Emerg Med
. 2020
;38
(5
):883
–9
. .21.
Loritz
M
, Busch
HJ
, Helbing
T
, Fink
K
. Prospective evaluation of the quickSOFA score as a screening for sepsis in the emergency department
. Intern Emerg Med
. 2020
;15
(4
):685
–93
.22.
Klimpel
J
, Weidhase
L
, Bernhard
M
, Gries
A
, Petros
S
. The impact of the sepsis-3 definition on ICU admission of patients with infection
. Scand J Trauma Resusc Emerg Med
. 2019
;27
(1
):98
. .23.
Ljungstrom
L
, Pernestig
AK
, Jacobsson
G
, Andersson
R
, Usener
B
, Tilevik
D
. Diagnostic accuracy of procalcitonin, neutrophil-lymphocyte count ratio, C-reactive protein, and lactate in patients with suspected bacterial sepsis
. PLoS One
. 2017
;12
(7
):e0181704
.24.
Kim
SJ
, Hwang
SO
, Kim
YW
, Lee
JH
, Cha
KC
. Procalcitonin as a diagnostic marker for sepsis/septic shock in the emergency department; a study based on sepsis-3 definition
. Am J Emerg Med
. 2019
;37
(2
):272
–6
. .25.
Rudd
KE
, Johnson
SC
, Agesa
KM
, Shackelford
KA
, Tsoi
D
, Kievlan
DR
, Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study
. Lancet
. 2020
;395
(10219
):200
–11
. .26.
Julian-Jimenez
A
, Yanez
MC
, Gonzalez-Del Castillo
J
, Salido-Mota
M
, Mora-Ordonez
B
, Arranz-Nieto
MJ
, Prognostic power of biomarkers for short-term mortality in the elderly patients seen in Emergency Departments due to infections
. Enferm Infecc Microbiol Clin
. 2019
;37
(1
):11
–8
.27.
Schuetz
P
, Birkhahn
R
, Sherwin
R
, Jones
AE
, Singer
A
, Kline
JA
, Serial procalcitonin predicts mortality in severe sepsis patients: results from the Multicenter Procalcitonin MOnitoring SEpsis (MOSES) Study
. Crit Care Med
. 2017
;45
(5
):781
–9
. .28.
Reith
HB
, Mittelkötter
U
, Wagner
R
, Thiede
A
. Procalcitonin (PCT) in patients with abdominal sepsis
. Intensive Care Med
. 2000
;26
(Suppl 2
):S165
–9
. .29.
Hausfater
P
, Garric
S
, Ayed
SB
, Rosenheim
M
, Bernard
M
, Riou
B
. Usefulness of procalcitonin as a marker of systemic infection in emergency department patients: a prospective study
. Clin Infect Dis
. 2002
;34
(7
):895
–901
. .30.
Mearelli
F
, Barbati
G
, Casarsa
C
, Giansante
C
, Breglia
A
, Spica
A
, The integration of qSOFA with clinical variables and serum biomarkers improves the prognostic value of qSOFA alone in patients with suspected or confirmed sepsis at ED admission
. J Clin Med
. 2020
;9
(4
):1205
. .31.
Saeed
K
, Wilson
DC
, Bloos
F
, Schuetz
P
, van der Does
Y
, Melander
O
, The early identification of disease progression in patients with suspected infection presenting to the emergency department: a multi-centre derivation and validation study
. Crit Care
. 2019
;23
(1
):40
. .32.
Liu
Z
, Meng
Z
, Li
Y
, Zhao
J
, Wu
S
, Gou
S
, Prognostic accuracy of the serum lactate level, the SOFA score and the qSOFA score for mortality among adults with sepsis
. Scand J Trauma Resusc Emerg Med
. 2019
;27
(1
):51
. .33.
Seymour
CW
, Liu
VX
, Iwashyna
TJ
, Brunkhorst
FM
, Rea
TD
, Scherag
A
, Assessment of clinical criteria for sepsis: for the third international consensus definitions for sepsis and septic shock (sepsis-3)
. JAMA
. 2016
;315
(8
):762
–74
. .34.
Ho
KM
, Lan
NS
. Combining quick sequential organ failure assessment with plasma lactate concentration is comparable to standard sequential organ failure assessment score in predicting mortality of patients with and without suspected infection
. J Crit Care
. 2017
;38
:1
–5
. .35.
Xia
Y
, Zou
L
, Li
D
, Qin
Q
, Hu
H
, Zhou
Y
, The ability of an improved qSOFA score to predict acute sepsis severity and prognosis among adult patients
. Medicine
. 2020
;99
(5
):e18942
. .36.
Yu
H
, Nie
L
, Liu
A
, Wu
K
, Hsein
YC
, Yen
DW
, Combining procalcitonin with the qSOFA and sepsis mortality prediction
. Medicine
. 2019
;98
(23
):e15981
. .© 2021 S. Karger AG, Basel
2021
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
